 electronucleonics ltenuc 2nd qtr dec 31 shr loss 177 dlrs profit 15 cts net loss 8036000 profit 576000 sales 162 mln 172 mln avg shrs 4539437 3816580 1st half shr loss 196 dlrs profit 26 cts net loss 8231000 profit 996000 sales 309 mln 322 mln avg shrs 4205707 3814141 note current half net includes 68000 dlr tax credit current year net periods includes 6700000 dlr writedown inventory clinical chemistry products